Fagron Sterile Services US Partners with Premier, Inc. for Compounded Preparations

Fagron Sterile Services US Secures National Agreement with Premier, Inc.

In a significant development within the pharmaceutical outsourcing industry, Fagron Sterile Services US (FSS) has been awarded a national group purchasing agreement with Premier, Inc.. This agreement, effective from July 1, 2025, will enable members of Premier to benefit from favorable pricing and conditions for outsourced compounded sterile preparations. This partnership symbolizes a crucial advancement in ensuring that healthcare providers across the nation have reliable access to high-quality, ready-to-administer medications.

Insights from Leadership

Ray Dixon, Senior Vice President of Commercial Operations for FSS, expressed the organization's commitment to supporting Premier members by providing a wide range of compounded preparations compliant with current good manufacturing practices (cGMP). He emphasized the importance of this partnership in enhancing accessibility and improving workflows involved in administering potentially life-saving medications. Dixon noted, "This award is not only a recognition of FSS's leadership in the global market but also an acknowledgment of our ongoing dedication to innovation, quality of service, and excellence in patient outcomes throughout the United States."

Importance of FSS in the Healthcare Sector

As medication shortages and rising costs pose serious challenges for healthcare systems nationwide, Fagron Sterile Services US plays an essential role in addressing these issues. By offering consistent and economical solutions for compounded sterile preparations, FSS helps to alleviate the pressures faced by hospitals and clinics. This agreement with Premier is a testament to their dedication to ensuring necessary medications are available at the point of care, effectively enhancing supply chain resilience in healthcare settings.

The move is particularly timely as the healthcare industry grapples with the complexities of managing medication supplies while providing quality care. The collaboration between Fagron and Premier represents a proactive approach designed to not only mitigate immediate challenges but also to forge a path for sustainable healthcare operations.

About Premier, Inc.

Premier, Inc. is renowned for being a technology-driven healthcare improvement company, servicing approximately two-thirds of all healthcare providers in the United States. The organization plays a vital role in the rapidly changing landscape of healthcare by uniting various stakeholders, including providers, suppliers, payers, and policymakers. Premier focuses on enhancing the quality of care while managing costs through actionable insights and innovative technologies.

Leveraging integrated data, analytics, and a suite of consulting services, Premier strives to elevate care standards across the board.

Conclusion

As Fagron Sterile Services US steps into this new partnership, it reaffirms its commitment to serving healthcare providers and ensuring the availability of critical medications. The collaboration stands as a beacon of hope for many, simplifying access to vital healthcare resources in a challenging and ever-evolving industry landscape. For more information about this agreement and Fagron's offerings, visit Fagron Sterile Services US.

To learn about Fagron and its contributions to pharmaceutical compounding worldwide, check out Fagron's website.